276 results match your criteria: "Center for Clinical Effectiveness[Affiliation]"
Jt Comm J Qual Saf
July 2004
Center for Clinical Effectiveness and Patient Safety, Medical University of South Carolina, Charleston, USA.
Background: The high cost of computerized physician order entry (CPOE) and physician resistance to standardized care have delayed implementation. An intranet-based order set system can provide some of CPOE's benefits and offer opportunities to acculturate physicians toward standardized care. INTRANET CLINICIAN ORDER FORMS (COF): The COF system at the Medical University of South Carolina (MUSC) allows caregivers to enter and print orders through the intranet at points of care and to access decision support resources.
View Article and Find Full Text PDFSpine (Phila Pa 1976)
April 2004
Center for Clinical Effectiveness, Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.
Study Design: Secondary analysis of Medical Expenditure Panel Survey from 1996 to 1999.
Objective: To examine patterns in opioid use in 1996, 1997, 1998, and 1999 among individuals with back pain in the United States and to investigate trends in the use of overall and individual opioid category.
Summary Of Background Data: To the authors' best knowledge, no study has examined at a national level the patterns and trends in opioid use among individuals with back pain in the United States.
Am J Obstet Gynecol
January 2004
Tulane Center for Clinical Effectiveness and Prevention, Tulane University School of Public Health, New Orleans, LA 70112, USA.
Objective: The purpose of this study was to explore the temporal trends and factors that are associated with cesarean deliveries and potentially unnecessary cesarean deliveries.
Study Design: The Louisiana birth certificate database was evaluated to identify a total of 57 potential indications/risk factors and maternal demographic factors that are associated with methods of delivery over the period from January 1993 to December 2000. A cesarean delivery without any potential indications/risk factors in the birth certificate was classified as unnecessary.
Spine (Phila Pa 1976)
January 2004
Center for Clinical Effectiveness, Division of Orthopedic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.
Study Design: Secondary analysis of the 1998 Medical Expenditure Panel Survey.
Objective: To estimate total health care expenditures incurred by individuals with back pain in the United States, calculate the incremental expenditures attributable to back pain among these individuals, and describe health care expenditure patterns of individuals with back pain.
Summary Of Background Data: There is a lack of updated information on health care expenditures and expenditure patterns for individuals with back pain in the United States.
Respir Care
December 2003
Center for Clinical Effectiveness and Patient Safety, Medical University of South Carolina, Charleston SC 29425, USA.
Clinical practice guidelines are systematically developed to assist health care decisions in specific clinical circumstances. They first arose to improve quality of care by decreasing unexplained practice variation, controlling health care costs, fostering evidence-based decision-making, and accelerating the application of new advances in medical science to everyday practice. Unfortunately, multiple studies demonstrate incomplete and varied effectiveness of clinical practice guidelines in altering clinician behavior and improving patient outcomes.
View Article and Find Full Text PDFJt Comm J Qual Saf
October 2003
Center for Clinical Effectiveness, Loyola University Health System, Maywood, Illinois, USA.
Background: Patient safety standards of the Joint Commission on Accreditation of Healthcare Organizations require that "patients and, when appropriate, their families are informed about the outcomes of care, including unanticipated outcomes."
What Outcomes Should Trigger Disclosure: Given that all medical treatments have an array of possible outcomes, how do we confidently say that an outcome is unanticipated? It is proposed that an adverse outcome meet one of two criteria to be considered unanticipated: (1) It would not be included in a reasonable informed consent process for treatment of the patient's condition(s) and/or would not be expected during the usual course of treatment; and (2) it may have been caused by human or systemic error--that is, it is not immediately possible to clearly and decisively rule out error. This definition requires less judgment because it represents an extension of the existing norms of communication that are expressed through the process of informed consent.
Spine (Phila Pa 1976)
August 2003
Center for Clinical Effectiveness, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
Study Design: Secondary analysis of data collected from spine patients' normal clinic visits from 1998 to 2001.
Objective: To evaluate the reliability, validity, and responsiveness of the short form 12-item survey in patients with back pain.
Summary Of Background Data: The reliability, validity, and responsiveness of the short form 12-item survey in patients with back pain has not been previously evaluated.
Pediatrics
August 2003
Center for Clinical Effectiveness, Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.
Objectives: Emergency department (ED) overcrowding has become a national problem. Children account for nearly 25% of overall ED visits. It has been reported that uninsured and publicly insured children are likely to visit the ED for urgent and nonurgent problems, yet it remains unclear to what extent health insurance status would influence children's overall ED utilization or ED utilization for nonurgent problems at the national level after controlling for other confounding factors.
View Article and Find Full Text PDFStroke
July 2003
Division of General Internal Medicine and the Center for Clinical Effectiveness, University of Cincinnati, Cincinnati, OH, USA.
Background And Purpose: Warfarin increases both the likelihood and the mortality of intracerebral hemorrhage (ICH), particularly in patients with a history of prior ICH. In light of this consideration, should a patient with both a history of ICH and a clear indication for anticoagulation such as nonvalvular atrial fibrillation be anticoagulated? In the absence of data from a clinical trial, we used a decision-analysis model to compare the expected values of 2 treatment strategies-warfarin and no anticoagulation-for such patients.
Methods: We used a Markov state transition decision model stratified by location of hemorrhage (lobar or deep hemispheric).
Med Decis Making
November 2002
Division of General Internal Medicine, Center for Clinical Effectiveness, University of Cincinnati, OH 45267-0535, USA.
Background: Survivors of venous thromboembolism who have the factor V Leiden mutation have an increased risk of recurrent venous thromboembolism (VTE), but the cost-effectiveness of testing for factor VLeiden has not been assessed.
Methods: We used a Markov state transition decision model to evaluate the cost-effectiveness of factor V Leiden testing and treatment strategies in survivors of VTE using a societal perspective for costs, effectiveness-measured in quality-adjusted life years, and incremental cost-effectiveness. Data sources included the English language literature using MEDLINE searches and bibliographies from selected articles.
Am Heart J
May 2001
Section of Outcomes Research, Department of Internal Medicine and Center for Clinical Effectiveness, Institute for Health Policy and Health Services Research, University of Cincinnati Medical Center, OH, USA.
Background: The objective of this study was to assess the cost-effectiveness of pravastatin therapy in survivors of myocardial infarction with average cholesterol levels.
Methods: We performed a cost-effectiveness analysis based on actual clinical, cost, and health-related quality-of-life data from the Cholesterol and Recurrent Events (CARE) trial. Survival and recurrent coronary heart disease events were modeled from trial data in Markov models, with the use of different assumptions regarding the long-term benefit of therapy.
Med Care
September 2000
Department of Internal Medicine, and Center for Clinical Effectiveness, Institute for Health Policy and Health Services Research, University of Cincinnati Medical Center, Ohio 45267-0535, USA.
Obstet Gynecol
September 1999
Department of Medicine, Center for Clinical Effectiveness, Loyola University Medical Center, Maywood, Illinois, USA.
Objective: To estimate the magnitude of laboratory testing for hypertension in pregnancy and determine whether abnormalities in prothrombin time (PT), activated partial thromboplastin time (aPTT), and fibrinogen can be predicted by results of common, less expensive tests.
Materials And Methods: Laboratory records were searched and charts were reviewed to identify gravidas tested for hypertension and to exclude conditions producing coagulopathy. Contingency tables were constructed to assess the ability of the platelet count, lactate dehydrogenase, and transaminases to predict coagulation test results.
J Natl Cancer Inst
September 1999
Josephine Ford Cancer Center and Center for Clinical Effectiveness, Henry Ford Health Sciences Center, Detroit, MI, USA.
Background: African-American women with breast cancer have poorer survival than European-American women. After adjustment for socioeconomic variables, survival differences diminish but do not disappear, possibly because of residual differences in health care access, biology, or behavior. This study compared breast cancer survival in African-American and European-American women with similar health care access.
View Article and Find Full Text PDFJ Thromb Thrombolysis
June 1999
Cardiovascular Division, Henry Ford Hospital Henry Ford Health System Center for Clinical Effectiveness, Detroit, Michigan 48202, USA.
Am J Respir Crit Care Med
August 1998
Division of Allergy and Clinical Immunology, Department of Biostatistics and Research Epidemiology, Center for Clinical Effectiveness, Henry Ford Health System, Detroit, Michigan, USA.
Managed care plan members provide a population for analysis that minimizes the financial barriers to routine medical care that have been linked to high rates of asthma-related hospitalization, emergency care, and mortality among urban African Americans. We examined patterns of asthma care among 464 African American (AA) and 1,609 Caucasian (C) asthma patients, age 15 to 45 yr, in a southeast Michigan managed care system during 1993. Compared with C, AA had fewer visits to asthma specialists (0.
View Article and Find Full Text PDFJ Gen Intern Med
July 1998
Center for Clinical Effectiveness, Henry Ford Health System, Detroit, Mich 48202, USA.
Objective: To compare the effects of different types of computer-generated, mailed reminders on the rate of influenza immunization and to analyze the relative cost-effectiveness of the reminders.
Design: Randomized controlled trial.
Setting: Multispecialty group practice.
Am J Ind Med
August 1998
Center for Clinical Effectiveness, Henry Ford Health System, Detroit, MI 48202, USA. or
This article reviews the analysis of a narrative text electronic search technique being used in the insurance industry. We reviewed a previously published study of motor vehicle crashes in roadway construction workzones as well as additional data supplied by the authors with respect to the methods of keyword selection. The narrative text search technique was evaluated with decision statistics and was found to have a sensitivity of 92.
View Article and Find Full Text PDFMed Care
December 1996
Center for Clinical Effectiveness, Henry Ford Health System, Detroit, MI 48202, USA.
Health Serv Res
December 1996
Center for Clinical Effectiveness, Henry Ford Health System, Detroit, MI 48202-3450, USA.
Objective: To identify factors associated with poor outcome after total hip replacement (THR) surgery.
Data Sources: This article is the first to present results from the American Medical Group Association (AMGA) THR consortium.
Study Design: The outcomes evaluated were pain and physical function.
Am J Prev Med
September 1996
Center for Clinical Effectiveness, Henry Ford Health System, Detroit, MI 48202, USA.
Mammography has been shown to be effective in decreasing breast cancer mortality. However, not all women receive recommended screening. The purpose of this study was to measure the effect of systemic health care delivery factors and patient demographic factors on the use of mammography among a population of women with insurance coverage for screening mammography.
View Article and Find Full Text PDFProc AMIA Annu Fall Symp
January 1997
Center for Clinical Effectiveness, Henry Ford Health System, Detroit, Michigan, USA.
Health care delivery institutions and providers, employers, and government agencies throughout the U.S. are sharing information and pooling resources in an attempt to produce reliable measurements of health outcomes.
View Article and Find Full Text PDFJ Pediatr
August 1995
Center for Clinical Effectiveness, University of Cincinnati and Children's Hospital Medical Center, OH, USA.
The effect of a cost-containment program focused on decreasing the lengths of hospital stay of high-risk neonates was assessed by comparison of discharge weights and lengths of stay for 257 study infants, discharged from a neonatal intensive care unit (NICU) after an early-discharge program began, with those of 477 control infants discharged during a prior 1-year period. Demographic data and costs, as well as data on emergency department use and hospital readmissions, were included in the comparisons. There was a significant decrease in mean discharge weight and length of stay for infants in the study group.
View Article and Find Full Text PDFJ Am Coll Cardiol
July 1995
Center for Clinical Effectiveness, Henry Ford Health System, Detroit, Michigan 48202, USA.
Objectives: This study sought to analyze the health and economic outcomes of withdrawal of digoxin therapy among U.S. adult patients with stable congestive heart failure.
View Article and Find Full Text PDFArch Intern Med
May 1993
Center for Clinical Effectiveness, Henry Ford Health System, Detroit, MI.
Background: The advent of effective prophylactic treatments for asymptomatic persons infected with human immunodeficiency virus has led to interest in widespread screening programs. However, the costs of screening programs and therapy are high, and the prevalence of infection above which screening becomes an appropriate use of scarce health care dollars remains undetermined.
Methods: To examine the cost-effectiveness of screening in populations with differing prevalences of infection, we developed a Markov model to compare costs and life expectancy for two strategies: (1) screening and prophylactic treatment for infected persons who have or who develop low CD4+ (T4) cell counts, and (2) no screening.